Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

Type 1 diabetes (T1D) arises from a failure to maintain tolerance to specific β-cell antigens. Antigen-specific immunotherapy (ASIT) aims to reestablish immune tolerance through the supply of pertinent antigens to specific cell types or environments that are suitable for eliciting tolerogenic respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Creusot, Rémi J., Postigo-Fernandez, Jorge, Teteloshvili, Nato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Methodology Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054431/
https://www.ncbi.nlm.nih.gov/pubmed/30030289
http://dx.doi.org/10.2337/db17-1564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054431/
https://www.ncbi.nlm.nih.gov/pubmed/30030289
http://dx.doi.org/10.2337/db17-1564

Ejemplares similares